Epigenetic gene silencing in cancer: the DNA hypermethylome
Open accessThe DOI matches its Crossref record; 99 of the 104 references it cites were found in a registry or an index.
Abstract
Epigenetic gene inactivation in transformed cells involves many 'belts of silencing'. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the epigenetic landscape of human malignancies exhibits massive reprogramming in their DNA methylation patterns.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Cancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,146
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Weber, M., Davies, J. J., Wittig, D., Oakeley, E. J., Haase, M., Lam, W. L., & Schübeler, D. (2005) · Nature Genetics · doi:10.1038/ng1598 · Cited by 1,754
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Chromatin signatures of pluripotent cell lines
Azuara, V., Perry, P., Sauer, S., Spivakov, M., Jørgensen, H. F., John, R. M., Gouti, M., Casanova, M., Warnes, G., Merkenschlager, M., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1403 · Cited by 1,353
DNA methylation profiling of human chromosomes 6, 20 and 22
Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V. K., Attwood, J., Burger, M., Burton, J., Cox, T. V., Davies, R., Down, T. A., et al. (2006) · Nature Genetics · doi:10.1038/ng1909 · Cited by 1,348
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
Polycomb silencers control cell fate, development and cancer
Sparmann, A., & van Lohuizen, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1991 · Cited by 1,303
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226 · cited 3×
“The use of epigenomic technologies for different acetylation and methylation modifications of histones (71,72) and methylated DNA (51,52) in embryonic stem cells provides a chromatin signature of pluripotent cell lines.”
BackgroundMethodEpigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Cellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142
Global histone modification patterns predict risk of prostate cancer recurrence
Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., & Kurdistani, S. K. (2005) · Nature · doi:10.1038/nature03672 · Cited by 1,092
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., et al. (2002) · Nature · doi:10.1038/416552a · Cited by 1,039
The Methyl-CpG-binding Protein MeCP2 Links DNA Methylation to Histone Methylation
Fuks, F., Hurd, P. J., Wolf, D., Nan, X., Bird, A. P., & Kouzarides, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210256200 · Cited by 994
Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
Thomson, J. M., Newman, M., Parker, J. S., Morin-Kensicki, E. M., Wright, T., & Hammond, S. M. (2006) · Genes & Development · doi:10.1101/gad.1444406 · Cited by 877
Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857
How microRNAs control cell division, differentiation and death
Miska, E. A. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.08.005 · Cited by 819
Di Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 787
Gonzalez‐Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T. T., Beart, R. W., Tornout, J. M. V., & Jones, P. A. (1995) · PubMed · Cited by 772
The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase
Fuks, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg332 · Cited by 760
RecQ helicases: caretakers of the genome
Hickson, I. D. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1012 · Cited by 680
Jones, P. A. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01636-9 · Cited by 665
EPSTKIN, C. J., MARTIN, G. M., SCHULTZ, A. L., & MOTULSKYS, A. G. (1966) · Medicine · doi:10.1097/00005792-196605000-00001 · Cited by 636
DNA methylation in the human γδβ-globin locus in erythroid and nonerythroid tissues
van der Ploeg, L. H. T., & Flavell, R. A. (1980) · Cell · doi:10.1016/0092-8674(80)90086-0 · Cited by 636
Nuclear Lamins: Laminopathies and Their Role in Premature Ageing
Broers, J. L. V., Ramaekers, F. C. S., Bonne, G., Yaou, R. B., & Hutchison, C. J. (2006) · Physiological Reviews · doi:10.1152/physrev.00047.2005 · Cited by 578
Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma
Greger, V., Passarge, E., H�pping, W., Messmer, E., & Horsthemke, B. (1989) · Human Genetics · doi:10.1007/bf00286709 · Cited by 574
ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISM
Esteller, M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095832 · Cited by 549
Evidence for an instructive mechanism of de novo methylation in cancer cells
Keshet, I., Schlesinger, Y., Farkash, S., Rand, E., Hecht, M., Segal, E., Pikarski, E., Young, R. A., Niveleau, A., Cedar, H., et al. (2006) · Nature Genetics · doi:10.1038/ng1719 · Cited by 478
Dnmt3a binds deacetylases and is recruited by a sequence‐specific repressor to silence transcription
Fuks, F., Burgers, W. A., Godin, N., Kasai, M., & Kouzarides, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2536 · Cited by 473
CpG methylation is maintained in human cancer cells lacking DNMT1
Rhee, I., Jair, K.-W., Yen, R.-W. C., Lengauer, C., Herman, J. G., Kinzler, K. W., Vogelstein, B., Baylin, S. B., & Schuebel, K. E. (2000) · Nature · doi:10.1038/35010000 · Cited by 453
Myc represses transcription through recruitment of DNA methyltransferase corepressor
Brenner, C., Deplus, R., Didelot, C., Loriot, A., Viré, E., De Smet, C., Gutierrez, A., Danovi, D., Bernard, D., Boon, T., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600509 · Cited by 445
Role for DNA methylation in the control of cell type–specific maspin expression
Futscher, B. W., Oshiro, M. M., Wozniak, R. J., Holtan, N., Hanigan, C. L., Duan, H., & Domann, F. E. (2002) · Nature Genetics · doi:10.1038/ng886 · Cited by 442
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
Esteller, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3001 · Cited by 441
Frigola, J., Song, J., Stirzaker, C., Hinshelwood, R. A., Peinado, M. A., & Clark, S. J. (2006) · Nature Genetics · doi:10.1038/ng1781 · Cited by 409
Comparative isoschizomer profiling of cytosine methylation: The HELP assay
Khulan, B., Thompson, R. F., Ye, K., Fazzari, M. J., Suzuki, M., Stasiek, E., Figueroa, M. E., Glass, J. L., Chen, Q., Montagna, C., et al. (2006) · Genome Research · doi:10.1101/gr.5273806 · Cited by 396
Specific DNA methylation sites in the vicinity of the chicken β-globin genes
MCGHEE, J. D., & GINDER, G. D. (1979) · Nature · doi:10.1038/280419a0 · Cited by 369
A systematic profile of DNA methylation in human cancer cell lines.
Paz, M. F., Fraga, M. F., Avila, S., Guo, M., Pollán, M., Herman, J. G., & Esteller, M. (2003) · PubMed · Cited by 367
Kim, G.-D. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf401 · Cited by 358
DNA Binding Selectivity of MeCP2 Due to a Requirement for A/T Sequences Adjacent to Methyl-CpG
Klose, R. J., Sarraf, S. A., Schmiedeberg, L., McDermott, S. M., Stancheva, I., & Bird, A. P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.07.021 · Cited by 344
Yamashita, K., Upadhyay, S., Osada, M., Hoque, M. O., Xiao, Y., Mori, M., Sato, F., Meltzer, S. J., & Sidransky, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00215-5 · Cited by 340
Esteller, M., & Herman, J. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207316 · Cited by 326
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer
Ballestar, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg604 · Cited by 320
Graff, J. R., Herman, J. G., Myöhänen, S., Baylin, S. B., & Vertino, P. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22322 · Cited by 319
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer
Agrelo, R., Cheng, W.-H., Setien, F., Ropero, S., Espada, J., Fraga, M. F., Herranz, M., Paz, M. F., Sanchez-Cespedes, M., Artiga, M. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600645103 · Cited by 264 · cited 20×
“WRN has a role in several pathways, such as DNA replication, DNA repair, p53-mediated pathways and telomere metabolism.”
BackgroundMethodInfluentialEpigenetic lesions causing genetic lesions in human cancer
Esteller, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00303-8 · Cited by 258
Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies
Smiraglia, D. J. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.13.1413 · Cited by 243
Stirzaker, C., Song, J. Z., Davidson, B., & Clark, S. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3690 · Cited by 240
Fraga, M. F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg249 · Cited by 238
Fraga, M. F., Herranz, M., Espada, J., Ballestar, E., Paz, M. F., Ropero, S., Erkek, E., Bozdogan, O., Peinado, H., Niveleau, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4061 · Cited by 213
A-type lamins: Guardians of the soma?
Hutchison, C. J., & Worman, H. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1062 · Cited by 208
Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors
Chen, W. Y., Zeng, X., Carter, M. G., Morrell, C. N., Chiu Yen, R.-W., Esteller, M., Watkins, D. N., Herman, J. G., Mankowski, J. L., & Baylin, S. B. (2003) · Nature Genetics · doi:10.1038/ng1077 · Cited by 201
Human DNA Methyltransferase 1 Is Required for Maintenance of the Histone H3 Modification Pattern
Espada, J., Ballestar, E., Fraga, M. F., Villar-Garea, A., Juarranz, A., Stockert, J. C., Robertson, K. D., Fuks, F., & Esteller, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404842200 · Cited by 198
The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia.
de Bustros, A., Nelkin, B. D., Silverman, A., Ehrlich, G., Poiesz, B., & Baylin, S. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5693 · Cited by 195
Opresko, P. L. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg034 · Cited by 187
Towards the Human Cancer Epigenome: A First Draft of Histone Modifications
Fraga, M. F., & Esteller, M. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2113 · Cited by 171
A Blueprint for a Human Epigenome Project: The AACR Human Epigenome Workshop
Jones, P. A., & Martienssen, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3865 · Cited by 169
The necessity of a human epigenome project
Esteller, M. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl033 · Cited by 166
Aging and Cancer: Issues of Basic and Clinical Science
Ershler, W. B., & Longo, D. L. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.20.1489 · Cited by 152
Crawford, Y., Gauthier, M. L., Joubel, A., Mantei, K., Kozakiewicz, K., Afshari, C. A., & Tlsty, T. D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00023-6 · Cited by 148
Lopez‐Serra, L., Ballestar, E., Fraga, M. F., Alaminos, M., Setién, F., & Esteller, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1932 · Cited by 143
Susceptibility of Nonpromoter CpG Islands to De Novo Methylation in Normal and Neoplastic Cells
Nguyen, C., Liang, G., Nguyen, T. T., Tsao-Wei, D. D., Groshen, S. G., Lübbert, M., Zhou, J., Benedict, W. F., & Jones, P. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.19.1465 · Cited by 142
Agrelo, R., Setién, F., Espada, J., Artiga, M. J., Rodríguez, M. E., Pérez‐Rosado, A., Sánchez‐Aguilera, A., Fraga, M. F., Piris, M. A., & Esteller, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.650 · Cited by 137
Cancer Epigenetics and Methylation
Esteller, M., Fraga, M. F., Paz, M. F., Campo, E., Colomer, D., Novo, F. J., Calasanz, M. J., Galm, O., Guo, M., Benitez, J. J., et al. (2002) · Science · doi:10.1126/science.297.5588.1807d · Cited by 135
Paz, M. F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg226 · Cited by 127
DNA motifs associated with aberrant CpG island methylation
Feltus, F. A., Lee, E. K., Costello, J., Plass, C., & Vertino, P. M. (2006) · Genomics · doi:10.1016/j.ygeno.2005.12.016 · Cited by 112
Epigenetic Cancer Therapy Makes Headway
Mack, G. S. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj447 · Cited by 110
Silencing of Bidirectional Promoters by DNA Methylation in Tumorigenesis
Shu, J., Jelı́nek, J., Chang, H., Shen, L., Qin, T., Chung, W., Oki, Y., & Issa, J. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2629 · Cited by 104
Ropero, S., Setién, F., Espada, J., Fraga, M. F., Herranz, M., Asp, J., Benassi, M. S., Franchi, A., Patiño‐García, A., Ward, L. S., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh298 · Cited by 102
Ying, J., Li, H., Cui, Y., Wong, A., Langford, C., & Tao, Q. (2006) · Leukemia · doi:10.1038/sj.leu.2404193 · Cited by 90
Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger
Ballestar, E., & Esteller, M. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-035 · Cited by 69
Heterochromatin: stable and unstable invasions at home and abroad
Fahrner, J. A., & Baylin, S. B. (2003) · Genes & Development · doi:10.1101/gad.1123303 · Cited by 62
Stadelmann, B., Khandjian, E. W., Hirt, A., Luthy, A. R., Weil, R., & Wagner, H. P. (1990) · Leukemia Research · doi:10.1016/0145-2126(90)90076-l · Cited by 59
Stimson, K. M., & Vertino, P. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109809200 · Cited by 55
The Role of Histone Modifications in Epigenetic Transitions During Normal and Perturbed Development
Kubicek, S., Schotta, G., Lachner, M., Sengupta, R., Kohlmaier, A., Perez-Burgos, L., Linderson, Y., Martens, J. H. A., O’Sullivan, R. J., Fodor, B. D., et al. (2006) · Springer eBooks · doi:10.1007/3-540-37633-x_1 · Cited by 50
Multiple binding of methyl‐CpG and polycomb proteins in long‐term gene silencing events
Matarazzo, M. R., Bonis, M. L. D., Strazzullo, M., Cerase, A., Ferraro, M., Vastarelli, P., Ballestar, E., Esteller, M., Kudo, S., & D’Esposito, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20879 · Cited by 41
Hisama, F. M., Bohr, V. A., & Oshima, J. (2006) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2006.10.pe18 · Cited by 13
Cited by
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
“MBD family members in turn recruit histone-modifying and chromatin-remodeling complexes to methylated site”
BackgroundHoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239
Emerging landscape of oncogenic signatures across human cancers
Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013) · Nature Genetics · doi:10.1038/ng.2762 · Cited by 1,378
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Kidney fibrosis: from mechanisms to therapeutic medicines
Huang, R., Fu, P., & Ma, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01379-7 · Cited by 781
“DNA methylation DNA methylation is a reaction by adding a methyl group to carbon 5 position of the cytosine residue (CpG site) which is catalyzed by DNA methyltransferases (DNMTs), usually contributing to the loss of gene expression.(170) Hypomethylation or DNA methylation on specific CpG site exert key functions in k…”
Background
Metadata
- Authors
- Esteller, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Esteller, Manel
- ORCID
- Esteller, Manel
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 16
- Issue
- R1
- Pages
- R50-R59
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2158207797
- Cited by
- 725
- References
- 104
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 34 · 2022: 35 · 2021: 29 · 2020: 17 · 2019: 35 · 2018: 38 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 36 · 2013: 56 · 2012: 62
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- epigenetic silencing, DNA hypermethylation, methylome, tumor suppressor, DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylase, histone methyltransferase, histone demethylase, Polycomb group proteins, DNA repair genes, microRNA, tumor markers, chemotherapy response prediction, epigenetic drugs, hematologic malignancies
- MeSH terms
- Werner Syndrome Helicase, Aging, Exodeoxyribonucleases, Humans, Neoplasms, RNA, Neoplasm, Werner Syndrome, Genes, Tumor Suppressor, CpG Islands, DNA Methylation, Gene Silencing, MicroRNAs, Epigenesis, Genetic, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.